Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Journal of Urology

• Publication date

  1995-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-5347(01)67064-2PMID 7541857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values.

  1994cited by this paper
• Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.

  1993cited by this paper
• Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels.

  1992cited by this paper
• Prostate specific antigen and prostatitis II. PSA production and release kinetics in vitro

  1992cited by this paper
• Prostate specific antigen and prostatitis I. Effect of prostatitis on serum psa in the human and nonhuman primate

  1992cited by this paper
• Elevation of prostate specific antigen from bacillus Calmette-Guerin-induced granulomatous prostatitis.

  1991cited by this paper
• Prostate‐specific antigen levels from completely sectioned, clinically benign, whole prostates

  1991cited by this paper
• Determination of prostate volume by transrectal ultrasound.

  1991cited by this paper
• Measurement of prostate-specific antigen in serum as a screening test for prostate cancer.

  1991cited by this paper
• Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma.

  1989cited by this paper
• The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations.

  1989cited by this paper
• Elevated serum prostate-specific antigen due to acute bacterial prostatitis.

  1989cited by this paper
• Transrectal ultrasonography in disorders of the seminal vesicles and ejaculatory ducts.

  1989cited by this paper
• Clinical use of prostate specific antigen in patients with prostate cancer.

  1989cited by this paper
• Ultrasonographic findings in prostatitis.

  1989cited by this paper
• Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.

  1988cited by this paper
• The ultrasound appearances of prostatic cancer with histological correlation.

  1987cited by this paper
• Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate

  1987cited by this paper
• Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study.

  1979cited by this paper
• Applied multiple regression/correlation analysis for the behavioral sciences

  1979cited by this paper
• Inflammatory changes in the non-infected prostate gland. A clinical, microbiological and histological investigation.

  1973cited by this paper
• Regional morphology and pathology of the prostate.

  1968cited by this paper
• Needle biopsy study of chronic prostatitis.

  1966cited by this paper
• Inflammation of the Prostate Gland1

  1937cited by this paper

• Prediction of clinically significant prostate cancer using extra-transitional zone prostate-specific antigen among Taiwanese men.

  2025cites this paper
• High-grade 18F-PSMA-1007 Uptake of Benign Prostatic Hyperplasia With Chronic Inflammation.

  2025cites this paper
• Association of prostate‐specific antigen density with prostate cancer mortality after a benign systematic prostate biopsy result

  2025cites this paper
• MRI-based risk stratification for clinically significant prostate cancer detection at biopsy: The value of zonal-specific PSA density and PSHS.

  2025cites this paper
• Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy

  2025cites this paper
• Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies

  2024cites this paper
• Spatio-temporal variation in prostate cancer testing in Stockholm: A population-based study

  2024cites this paper
• An epitope imprinted electrochemical sensor for highly sensitive and selective determination of prostate-specific antigen

  2024cites this paper
• Analysis of Inflammatory Features in Suspicious Lesions for Significant Prostate Cancer on Magnetic Resonance Imaging—Are They Mimickers of Prostate Cancer?

  2024cites this paper
• Predictive value of neutrophil-to-lymphocyte ratio for clinically significant prostate cancer

  2024cites this paper
• Preliminary effects of risk-adapted PSA screening for prostate cancer after integrating PRS-specific and age-specific variation

  2024cites this paper
• Prostate cancer extracellular vesicle digital scoring assay - a rapid noninvasive approach for quantification of disease-relevant mRNAs.

  2023cites this paper
• Serum prostate-specific antigen trends and prostate cancer detection on follow-up in men with a prior negative biopsy: A cohort study

  2023cites this paper
• A systematic review identifying seminal plasma biomarkers and their predictive ability on IVF and ICSI outcomes.

  2023cites this paper
• Inflammation and Prostate Cancer: Pathological Analysis from Pros-IT CNR 2

  2023cites this paper
• Navigating the Diagnostic Maze: Unraveling the Non-invasive Evaluation of Bladder Outlet Obstruction in Men—a Comprehensive Systematic Review

  2023cites this paper
• Correlação entre ressonância magnética multiparamétrica com escore PI-RADS V2 com análise anatomopatológica de pacientes submetidos à biópsia prostática

  2023cites this paper
• Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection

  2023cites this paper
• Digital rectal examination impact on PSA derivatives and prostate biopsy triggers: a contemporary study

  2022cites this paper
• Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future

  2022cites this paper
• Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays

  2022cites this paper
• Comparison of PSA density and lesion volume strategies for selecting men with equivocal PI-RADS 3 lesions on bpMRI for biopsies

  2022cites this paper
• The Effect of Ofloxacin on Prostate Specific Antigen Level in Men with High Antigen

  2022cites this paper
• Review article: A variable level of prostate specific antigen and its relative tests and their probable explanatory diagnosis

  2022cites this paper
• Prostate Cancer-Associated miRNAs in Saliva: First Steps to an Easily Accessible and Reliable Screening Tool

  2022cites this paper
• Kinetic Analysis of Prostate-Specific Antigen Interaction with Monoclonal Antibodies for Development of a Magnetic Immunoassay Based on Nontransparent Fiber Structures

  2022cites this paper
• The modified prostate health index (PHI) outperforms PHI density in the detection of clinical prostate cancer within the PSA grey zone

  2022cites this paper
• Genetic variant located on chromosome 17p12 contributes to prostate cancer onset and biochemical recurrence

  2022cites this paper
• A Deep Learning Model for Prostate Adenocarcinoma Classification in Needle Biopsy Whole-Slide Images Using Transfer Learning

  2022cites this paper
• Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation

  2021cites this paper
• Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer

  2021cites this paper
• Linear Model Selection and Regularization for Serum Prostate-Specific Antigen Prediction of Patients With Prostate Cancer Using R

  2021cites this paper
• Circular RNAs in prostate cancer: Biogenesis,biological functions, and clinical significance

  2021cites this paper
• Performance comparison of anti-p504s (SP116) Rabbit Monoclonal Primary Antibody vs. Monoclonal Rabbit Anti-Human AMACR clone 13H4 when duplexed with VENTANA Basal Cell Cocktail (34βE12+p63) as a diagnostic aid for prostatic adenocarcinoma using immunohistochemistry

  2021cites this paper
• ProCanBio: A Database of Manually Curated Biomarkers for Prostate Cancer

  2021cites this paper
• Inhibitors of prostate-specific membrane antigen in the diagnosis and therapy of metastatic prostate cancer – a review of patent literature

  2021cites this paper
• Evaluation of cell‐free DNA accuracy as diagnostic biomarker for prostate cancer: A systematic review and meta‐analysis

  2021cites this paper
• Total thiol can contribute to differentiating prostate cancer from BPH: Prostate Thiol Index as a new player

  2021cites this paper
• A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer

  2021cites this paper
• Haralick texture features extracted from Ga-68 PSMA PET/CT to differentiate normal prostate from prostate cancer: a feasibility study

  2021cites this paper
• Efficacy and safety of onabotulinumtoxinA in patients with overactive bladder: subgroup analyses by sex and by serum prostate-specific antigen levels in men from a randomized controlled trial

  2021cites this paper
• Contributions of Social Factors to Disparities in Prostate Cancer Risk Profiles among Black Men and Non-Hispanic White Men with Prostate Cancer in California

  2021cites this paper
• Synthesis and evaluation of new peptide-linked doxorubicin conjugates as prodrugs activated by prostate-specific antigen

  2020cites this paper
• Understanding the diagnosis of prostate cancer

  2020cites this paper
• Synthesis and evaluation of new 4-peptidamido-2-fluorobenzyl phosphoramide mustard conjugates as prodrugs activated by prostate-specific antigen

  2020influential citation
• Tobacco and marijuana use and their association with serum prostate-specific antigen levels among African American men in Chicago

  2020cites this paper
• Role of prostate specific antigen and prostate specific antigen density as biomarkers for medical and surgical treatment response in men with lower urinary tract symptoms: a systematic review and meta-analysis.

  2020cites this paper
• Prostate Biopsy up Date

  2020cites this paper
• Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk

  2020cites this paper
• Highly Selective Optical Sensor Eu (TTA)3 Phen Embedded in Poly Methylmethacrylate for Assessment of Total Prostate Specific Antigen Tumor Marker in Male Serum Suffering Prostate Diseases

  2020cites this paper
• Diagnostic significance of miR‐21, miR‐141, miR‐18a and miR‐221 as novel biomarkers in prostate cancer among Egyptian patients

  2019cites this paper
• Дiагностична цiннiсть iндексу здоров’я простати у ранньому виявленнi раку передмiхурової залози (огляд лiтератури)

  2019cites this paper
• Baseline Prostate-specific Antigen Level in Midlife and Aggressive Prostate Cancer in Black Men.

  2019cites this paper
• A Comprehensive Genome-Wide and Phenome-Wide Examination of BMI and Obesity in a Northern Nevadan Cohort

  2019cites this paper
• Development and validation of methods for the diagnosis of lung cancer via serological biomarkers

  2019cites this paper
• Current Knowledge of the Potential Links between Inflammation and Prostate Cancer

  2019cites this paper
• Does extent of prostate-specific antigen fluctuation can predict Gleason score upgrading in low-risk prostate cancer patients?

  2019cites this paper
• The association between clinically determined periodontal disease and prostate-specific antigen concentration in men without prostate cancer: the 2009–2010 National Health and Nutrition Examination Survey

  2019cites this paper
• PSMA-Expression in Prostatakarzinomgewebe und auf zirkulierenden Tumorzellen bei Patienten mit metastasiertem Prostatakarzinom

  2019cites this paper
• Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use

  2019cites this paper
• Serum PSA levels in patients with prostate cancer and other 33 different types of diseases.

  2019cites this paper
• Diagnosis of prostate cancer

  2019cites this paper
• Clinical Utility of Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Diagnostic Tool and Potential Therapeutic Target in Prostate Cancer

  2019cites this paper
• Disorders of the prostate: Lower urinary tract obstruction and prostatitis

  2019cites this paper
• In Vivo Detection of Circulating Tumor Cells in High-Risk Non-Metastatic Prostate Cancer Patients Undergoing Radiotherapy

  2019cites this paper
• Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate Cancer

  2019cites this paper
• Antibiotic therapy in patients with high prostate-specific antigen: Is it worth considering? A systematic review

  2019cites this paper
• Re: Classification of Prostate Cancer Using a Protease Activity Nanosensor Library.

  2019cites this paper
• Relation of Age and Serum Prostatic-Specific Antigen level with Histopathological diagnosis in Transurethral Resection of Prostate specimen, an Experience from Eastern Tertiary Hospital

  2019cites this paper
• Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA

  2018cites this paper
• Plasma ghrelin O‐acyltransferase (GOAT) enzyme levels: A novel non‐invasive diagnosis tool for patients with significant prostate cancer

  2018cites this paper
• Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker

  2018cites this paper
• RNAs as Candidate Diagnostic and Prognostic Markers of Prostate Cancer—From Cell Line Models to Liquid Biopsies

  2018cites this paper
• Spina Bifida Health-care Guidelines for Men's Health.

  2018cites this paper
• PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study

  2018cites this paper
• Expression patterns and bioinformatic analysis of miR-1260a and miR-1274a in Prostate Cancer Tunisian patients

  2018cites this paper
• Stratification of PSA Response to Empirical Antibiotic Therapy to Predict the Possibility of Prostate Cancer in TRUS Biopsy

  2018influential citation
• Étude des implications biochimiques et moléculaires sous-jacentes à la pharmacothérapie ciblée contre la proprotéine convertase PACE4 dans le cancer de la prostate

  2018cites this paper
• Physiological variables and molecular study of KLK2 and KLK3 among patient with benign prostatic hyperplasia

  2018cites this paper
• Photoacoustic tomography of intact human prostates and vascular texture analysis identify prostate cancer biopsy targets

  2018cites this paper
• Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL

  2018cites this paper
• Stage T3b prostate cancer diagnosed by seminal vesicle biopsy and treated with neoadjuvant hormone therapy, permanent brachytherapy and external beam radiotherapy

  2018cites this paper
• Molecular strategies to reduce unnecessary repeat prostate biopsies of men with elevated serum PSA

  2018cites this paper
• Blood-based microRNAs as diagnostic biomarkers to discriminate localized prostate cancer from benign prostatic hyperplasia and allow cancer-risk stratification.

  2018cites this paper
• Hyperpolarized 13C magnetic resonance imaging, using metabolic imaging to improve the detection and management of prostate, bladder, and kidney urologic malignancies

  2018cites this paper
• 8 Strategies for Repeat Prostate Biopsies

  2018cites this paper
• Unveiling the Link between Prostatitis and Periodontitis

  2018cites this paper
• Spontaneous Progressive Diminution of Prostate-Specific Antigen Levels as a Clue to Secondary Hypogonadism and Ultimately a Pituitary Macroadenoma

  2018cites this paper
• Circulating platelets : a novel liquid biopsy source for cancer diagnostics and therapy stratification

  2018cites this paper
• Classification of prostate cancer using a protease activity nanosensor library

  2018cites this paper
• Diagnosis in Prostate Cancer

  2018cites this paper
• Comparative Proteomics Analysis of Urine Reveals Down-Regulation of Acute Phase Response Signaling and LXR/RXR Activation Pathways in Prostate Cancer

  2017cites this paper
• A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer

  2017cites this paper
• PSA and Prostate Health Index based prostate cancer screening in a hereditary migration complicated population: implications in precision diagnosis

  2017cites this paper
• Association between systemic inflammation and serum prostate-specific antigen in a healthy Korean population.

  2017cites this paper
• Development and External Validation of the Korean Prostate Cancer Risk Calculator for High-Grade Prostate Cancer: Comparison with Two Western Risk Calculators in an Asian Cohort

  2017cites this paper
• Effect of Levisticum officinale Hydroalcoholic Extract on DU-145 and PC-3 Prostate Cancer Cell Lines

  2017cites this paper
• Beyond the PSA test: How to better stratify a patient's risk of prostate cancer.

  2017cites this paper
• Elevated Serum PSA is Associated With Human Herpesvirus 8 Infection and Increased Circulating Cytokine Levels in Men From Tobago

  2017cites this paper
• Investigating engrailed-2 (EN2) as a therapeutic target in prostate cancer

  2017cites this paper